Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes

Graham H. Bothamley

Source: ERJ Open Res, 8 (4) 00512-2022; 10.1183/23120541.00512-2022

Journal Issue: October

Abstract

In this issue of ERJ Open Research, Korhonen et al. [1] describe their experience of multidrug-resistant tuberculosis (MDR-TB) in Finland from 2007 to 2016. 47 clinical cases were included and act as historical background to the major changes in treatment regimens proposed by the World Health Organization (WHO) [2].

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Graham H. Bothamley. Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes. ERJ Open Res, 8 (4) 00512-2022; 10.1183/23120541.00512-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.